TRIFARMA
TRIFARMA, officially known as TRIFARMA S.p.A., is a prominent player in the pharmaceutical industry, headquartered in Italy. Established in 2000, the company has made significant strides in the development and distribution of innovative healthcare solutions across Europe and beyond. Specialising in the production of high-quality generic medicines and over-the-counter products, TRIFARMA stands out for its commitment to rigorous quality standards and advanced research methodologies. The company’s extensive portfolio includes a diverse range of therapeutic areas, catering to both prescription and non-prescription markets. With a strong market presence and a reputation for excellence, TRIFARMA has achieved notable milestones, including strategic partnerships and a growing international footprint. Its dedication to improving patient outcomes positions TRIFARMA as a trusted name in the pharmaceutical sector.
DitchCarbon Score
How does TRIFARMA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
TRIFARMA's score of 3 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
TRIFARMA's reported carbon emissions
TRIFARMA, headquartered in Italy, currently does not have publicly available carbon emissions data for recent years. As a result, specific figures regarding their Scope 1, 2, or 3 emissions are not provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. In the absence of specific emissions data, it is important to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate commitments. This often includes setting science-based targets for emissions reductions and engaging in initiatives aimed at minimising their carbon footprint. TRIFARMA's approach to climate action remains unclear without detailed information on their emissions or commitments. However, the industry trend suggests a growing emphasis on transparency and accountability in addressing climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
TRIFARMA is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
